Loading...
XSTO
ORTI B
Market cap3mUSD
Jul 09, Last price  
1.74SEK
1D
0.00%
1Q
22.54%
Jan 2017
-25.80%
Name

Ortivus AB

Chart & Performance

D1W1MN
XSTO:ORTI B chart
P/E
—
P/S
0.48
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.04%
Rev. gr., 5y
-7.36%
Revenues
73m
-8.72%
199,776,000162,408,00083,113,000105,039,00047,726,00045,748,00060,710,00036,105,00069,366,00072,619,00074,279,00058,799,00052,200,00050,848,000107,582,00094,272,000104,509,00084,081,00080,413,00073,401,000
Net income
-22m
L-12.16%
-149,186,000-61,289,000-68,946,000-18,480,000-22,271,000-37,860,0002,220,000-14,043,0001,400,000-7,090,000-7,079,000-11,605,000-13,391,000-16,006,00011,332,0009,211,0005,892,000-18,245,000-24,903,000-21,876,000
CFO
-25m
L+158.92%
-40,418,000-1,396,000-18,976,000-10,052,000-26,694,000-8,688,0008,946,000-7,128,00031,934,000-3,387,0004,935,000-11,898,000-510,000-3,510,00018,630,0007,774,000-6,878,000-303,000-9,747,000-25,237,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides ambulance services, primary care, and rescue services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden. Ortivus AB (publ) is a subsidiary of Ponderus Invest AB.
URL
https://www.ortivus.com/
IPO date
Jan 02, 1997
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT